Collagen homeostasis of the left atrium: an emerging treatment target to prevent heart failure?

This article refers to 'Biomarker-based assessment of collagen cross-linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial remodelling. Insights from the HOMAGE clinical trial' by S. Ravassa et al., published in this issue on pages 321-331.